205 related articles for article (PubMed ID: 29081307)
61. Pharmacotherapy of generalized anxiety disorder: results of duloxetine treatment from a pooled analysis of three clinical trials.
Allgulander C; Hartford J; Russell J; Ball S; Erickson J; Raskin J; Rynn M
Curr Med Res Opin; 2007 Jun; 23(6):1245-52. PubMed ID: 17559726
[TBL] [Abstract][Full Text] [Related]
62. Vortioxetine for generalised anxiety disorder in adults.
Meza N; Leyton F
Medwave; 2021 Apr; 21(3):e8172. PubMed ID: 34038400
[TBL] [Abstract][Full Text] [Related]
63. Duloxetine treatment for relapse prevention in adults with generalized anxiety disorder: a double-blind placebo-controlled trial.
Davidson JR; Wittchen HU; Llorca PM; Erickson J; Detke M; Ball SG; Russell JM
Eur Neuropsychopharmacol; 2008 Sep; 18(9):673-81. PubMed ID: 18559291
[TBL] [Abstract][Full Text] [Related]
64. Efficacy and tolerability of extended release quetiapine fumarate monotherapy in the acute treatment of generalized anxiety disorder: a randomized, placebo controlled and active-controlled study.
Merideth C; Cutler AJ; She F; Eriksson H
Int Clin Psychopharmacol; 2012 Jan; 27(1):40-54. PubMed ID: 22045039
[TBL] [Abstract][Full Text] [Related]
65. Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder.
Davidson JR; DuPont RL; Hedges D; Haskins JT
J Clin Psychiatry; 1999 Aug; 60(8):528-35. PubMed ID: 10485635
[TBL] [Abstract][Full Text] [Related]
66. The safety and efficacy of ipsapirone vs. lorazepam in outpatients with generalized anxiety disorder (GAD): single site findings from a multicenter trial.
Cutler NR; Sramek JJ; Wardle TS; Hesselink JM; Roeschen JK
Psychopharmacol Bull; 1993; 29(2):303-8. PubMed ID: 7904761
[TBL] [Abstract][Full Text] [Related]
67. Early improvement with pregabalin predicts endpoint response in patients with generalized anxiety disorder: an integrated and predictive data analysis.
Montgomery SA; Lyndon G; Almas M; Whalen E; Prieto R
Int Clin Psychopharmacol; 2017 Jan; 32(1):41-48. PubMed ID: 27583543
[TBL] [Abstract][Full Text] [Related]
68. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.
Rickels K; Pollack MH; Feltner DE; Lydiard RB; Zimbroff DL; Bielski RJ; Tobias K; Brock JD; Zornberg GL; Pande AC
Arch Gen Psychiatry; 2005 Sep; 62(9):1022-30. PubMed ID: 16143734
[TBL] [Abstract][Full Text] [Related]
69. Ziprasidone treatment of refractory generalized anxiety disorder: a placebo-controlled, double-blind study.
Lohoff FW; Etemad B; Mandos LA; Gallop R; Rickels K
J Clin Psychopharmacol; 2010 Apr; 30(2):185-9. PubMed ID: 20520293
[TBL] [Abstract][Full Text] [Related]
70. Anxiety symptoms in working patients with major depressive disorder treated with vortioxetine: associations with clinical and treatment outcomes in the AtWoRC study.
Chokka P; Ge H; Bougie J; Ettrup A; Clerzius G
Ther Adv Psychopharmacol; 2021; 11():20451253211013148. PubMed ID: 34025982
[TBL] [Abstract][Full Text] [Related]
71. Effectiveness of Vortioxetine in Working Patients with Major Depressive Disorder in China: A Subgroup Analysis of the RELIEVE China Study.
Wang G; Si T; Rieckmann A; Ma J; Christensen MC
Neuropsychiatr Dis Treat; 2024; 20():1211-1223. PubMed ID: 38863483
[TBL] [Abstract][Full Text] [Related]
72. Efficacy of Vortioxetine on Anhedonia: Results from a Pooled Analysis of Short-Term Studies in Patients with Major Depressive Disorder.
McIntyre RS; Loft H; Christensen MC
Neuropsychiatr Dis Treat; 2021; 17():575-585. PubMed ID: 33654400
[TBL] [Abstract][Full Text] [Related]
73. Comparative efficacy and acceptability of first-line drugs for the acute treatment of generalized anxiety disorder in adults: A network meta-analysis.
He H; Xiang Y; Gao F; Bai L; Gao F; Fan Y; Lyu J; Ma X
J Psychiatr Res; 2019 Nov; 118():21-30. PubMed ID: 31473564
[TBL] [Abstract][Full Text] [Related]
74. Vortioxetine in the Treatment of Mood Disorders Associated with Burning Mouth Syndrome: Results of an Open-Label, Flexible-Dose Pilot Study.
Adamo D; Pecoraro G; Aria M; Favia G; Mignogna MD
Pain Med; 2020 Jan; 21(1):185-194. PubMed ID: 31343684
[TBL] [Abstract][Full Text] [Related]
75. Vortioxetine improves physical and cognitive symptoms in patients with post-COVID-19 major depressive episodes.
Di Nicola M; Pepe M; Montanari S; Spera MC; Panaccione I; Simonetti A; Sani G
Eur Neuropsychopharmacol; 2023 May; 70():21-28. PubMed ID: 36808043
[TBL] [Abstract][Full Text] [Related]
76. A double-blind, placebo-controlled study of vortioxetine in the treatment of binge-eating disorder.
Grant JE; Valle S; Cavic E; Redden SA; Chamberlain SR
Int J Eat Disord; 2019 Jul; 52(7):786-794. PubMed ID: 30938842
[TBL] [Abstract][Full Text] [Related]
77. Impact of vortioxetine on psychosocial functioning moderated by symptoms of fatigue in post-COVID-19 condition: a secondary analysis.
Badulescu S; Le GH; Wong S; Kwan ATH; Guo Z; Teopiz KM; Phan L; Subramaniapillai M; Rosenblat JD; Mansur RB; McIntyre RS
Neurol Sci; 2024 Apr; 45(4):1335-1342. PubMed ID: 38321333
[TBL] [Abstract][Full Text] [Related]
78. The efficacy and safety of multiple doses of vortioxetine for generalized anxiety disorder: a meta-analysis.
Fu J; Peng L; Li X
Neuropsychiatr Dis Treat; 2016; 12():951-9. PubMed ID: 27143896
[TBL] [Abstract][Full Text] [Related]
79. Real-world effectiveness of vortioxetine in outpatients with major depressive disorder: functioning and dose effects.
Papalexi E; Galanopoulos A; Kontis D; Markopoulou M; Balta G; Karavelas E; Panagiotidis P; Vlachos T; Ettrup A
BMC Psychiatry; 2022 Aug; 22(1):548. PubMed ID: 35962369
[TBL] [Abstract][Full Text] [Related]
80. Impact of vortioxetine on depressive symptoms moderated by symptoms of anxiety in persons with post-COVID-19 condition: A secondary analysis.
Le GH; Kwan ATH; Guo Z; Teopiz KM; Wong S; Meshkat S; d'Andrea G; Ho R; Rhee TG; Cao B; Badulescu S; Phan L; Rosenblat JD; Mansur RB; Subramaniapillai M; McIntyre RS
Psychiatry Res; 2024 Jun; 339():116068. PubMed ID: 38954891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
